- 4-Week # shares sold: 3,300
- 12-Week # shares sold: 3,300
- 24-Week # shares sold: 3,300
Some recent high-flying biotechs may be preparing for their next surge.
Jim Cramer is bullish on Exelon and Valley National Bancorp, but he's bearish on AxoGen and SeaDrill Limited.
Political negatives keep popping up, forcing us to rethink the Trump trade, says Jim Cramer.